GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rhythm Pharmaceuticals Inc (STU:1RV) » Definitions » Float Percentage Of Total Shares Outstanding

Rhythm Pharmaceuticals (STU:1RV) Float Percentage Of Total Shares Outstanding : 65.31% (As of Jun. 10, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Rhythm Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Rhythm Pharmaceuticals's float shares is 39.82 Mil. Rhythm Pharmaceuticals's total shares outstanding is 60.97 Mil. Rhythm Pharmaceuticals's float percentage of total shares outstanding is 65.31%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Rhythm Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Rhythm Pharmaceuticals's Institutional Ownership is 55.72%.

Rhythm Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Rhythm Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=39.82/60.97
=65.31%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhythm Pharmaceuticals (STU:1RV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rhythm Pharmaceuticals Inc (STU:1RV) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
PNT SMMT CPRX SWTX PTCT VCYT HRMY BEAM ABCL MRUS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
RYTM:USA RYTM:Mexico
Address
222 Berkeley Street, 12th Floor, Boston, MA, USA, 02116
Website
http://www.rhythmtx.com
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies.

Rhythm Pharmaceuticals (STU:1RV) Headlines

No Headlines